A Pharmaceuticals and Healthcare (Contract Research & Manufacturing Services (CRAMS)) entity from India is looking to sellout.

Posted By - Investment Banker Posted date - 29/08/2020

BUSINESS BRIEF

The Company has WHO GMP Approved and US FDA authorized manufacturing unit producing Injectables, Tablets, Eyes/Ear drops. The operations of the firm closed in 2017 due to Working Capital crunch, more than 60 equipments are in reusable condition. The Company has 20 acre land, All QA-QC Equipments are in place, RO Water / HEPA filter functional, and more than 60 product licenses are available. Upgradation for additional production is also possible The turnaround time would be 100 working days. along with the availability of all documents for due diligence.

Proposal
Icon

Industry

Pharmaceuticals

Icon

Sub Industry

Contract Research & Manufacturing Services (CRAMS)

Icon

Deal Size

INR 45 - 55 Cr

Icon

Motives For Sellout

Raising Capital

Entity is open for Investor Keen on Special Situations/distress assets funding

Business Operation Information
Financial Information
 2018 (in Cr) 2019 (in Cr) 2020 (in Cr) 2021 (in Cr)
Sales
 N.D N.D N.D N.D
EBITDA
 N.D N.D N.D N.D
PAT
 N.D N.D N.D N.D
TOTAL DEBT
 N.D N.D N.D N.D
Business Documents